Related Experiment Videos
Propofol inhibits human neutrophil functions
K Mikawa1, H Akamatsu, K Nishina
1Department of Anaesthesiology, Kobe University School of Medicine, Japan.
Anesthesia and Analgesia
|September 5, 1998
Summary
Propofol, an anesthetic, impairs key neutrophil functions like chemotaxis and phagocytosis at clinically relevant doses. This suggests potential impacts on the immune system
Area of Science:
- Immunology
- Anesthesiology
- Cell Biology
Background:
- Neutrophils are crucial for antibacterial defense and tissue injury.
- Propofol is known to affect reactive oxygen species (ROS) production in neutrophils.
Purpose of the Study:
- To investigate the in vitro effects of propofol on human neutrophil functions.
- To determine the dose-dependent impact of propofol on neutrophil chemotaxis, phagocytosis, and ROS production.
Main Methods:
- In vitro assessment of human neutrophils exposed to propofol at various concentrations.
- Measurement of chemotaxis, phagocytosis, and reactive oxygen species (ROS) production.
- Analysis of intracellular calcium ([Ca2+]i) levels following N-formyl-L-methionyl-L-leucyl-L-phenylalanine stimulation.
Main Results:
- Propofol significantly inhibited neutrophil chemotaxis, phagocytosis, and ROS production in a dose-dependent manner.
- These inhibitory effects were observed at clinically relevant propofol concentrations.
- Propofol attenuated the increase in intracellular calcium ([Ca2+]i) in stimulated neutrophils.
Conclusions:
- Propofol impairs critical human neutrophil functions, including chemotaxis, phagocytosis, and ROS generation.
- The observed inhibition of neutrophil functions by propofol may be linked to its effect on intracellular calcium levels.
- Further research is needed to ascertain if these in vitro findings translate to clinical immunological suppression.